Alshehri, E. (2026) The Diagnostic Conundrum of Recurrent High-Grade Vaginal Intraepithelial Neoplasia (VAIN) Following ...

FREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc (PSNL). (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced the presentation of new results from the CALLA phase 3 study ...

Cervical cancer remains one of the most challenging diseases in oncology, with high recurrence rates and significant treatment side effects. For decades, the standard approach has relied on a ...

Tivdak is a tissue factor-directed antibody and microtubule inhibitor conjugate. The Food and Drug Administration (FDA) has granted full approval to Tivdak ® (tisotumab vedotin-tftv) for the treatment ...

Cervical cancer is a serious type of cancer and its recurrence after treatment is an issue doctors want to address. Experts are interested in finding the best combination of therapies to treat ...

This study, innovaTV 301, was a phase 3, multinational, open-label trial (n = 502) of tisotumab vedotin as a second- or third-line therapy compared with the investigator's choice of chemotherapy. The ...

Early detection and modern treatments make cervical cancer one of the most preventable and treatable cancers. Newport Women’s ...

A new computer model may be able to forecast cervical cancer recurrence in an individual based on how the tumor changes in size after the first rounds of radiation therapy, a team of researchers ...

In a population-based cohort of 15- to 39-year-olds diagnosed with cancer, the risk for metastatic recurrence varied widely by cancer type and stage, and survival after recurrence was worse than after ...

Top line data show that the randomized Phase II study of TG4001 in combination with avelumab versus avelumab alone in patients with recurrent or metastatic HPV16-positive cervical and anogenital ...

“We are excited to see the results presented for NeXT Personal in this large phase 3 study in cervical cancer,” said Richard Chen, MD, Chief Medical Officer and Executive Vice President, R&D at ...

Share on Pinterest A new phase 3 trial finds that combining therapies may improve putcomes in cervical cancer. SeventyFour/Getty Images Cervical cancer is a serious type of cancer and its recurrence ...